Acquisition Announced

Eli Lilly acquisition of Engage Bio

US$202m consideration

Announced 20 May 2026

Advisers

Target
Engage Bio
Acquirer
Eli Lilly
Target based in
United States (unverified)
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.